Vita Life Sciences Dividend

Dividend criteriumcontroles 4/6

Vita Life Sciences is een dividendbetalend bedrijf met een huidig rendement van 4.04% dat ruimschoots wordt gedekt door de winst.

Belangrijke informatie

4.1%

Dividendrendement

55%

Uitbetalingsratio

Gemiddelde opbrengst industrie	2.2%
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	AU$0.090
Winst per aandeel	AU$0.16
Dividendrendementsvoorspelling	n/a

Recente dividendupdates

Recent updates

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: De dividendbetalingen van VLS zijn de afgelopen 10 jaar volatiel geweest.

Groeiend dividend: De dividendbetalingen van VLS zijn de afgelopen 10 jaar gestegen.

Dividendrendement versus markt

Vita Life Sciences Dividendrendement versus markt

Hoe verhoudt VLS dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (VLS)	4.1%
Markt onderkant 25% (AU)	2.6%
Markt Top 25% (AU)	6.0%
Gemiddelde industrie (Pharmaceuticals)	2.2%
Analist prognose (VLS) (tot 3 jaar)	n/a

Opmerkelijk dividend: Het dividend van VLS ( 4.04% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de Australian markt ( 2.62% ).

Hoog dividend: Het dividend VLS ( 4.04% ) is laag vergeleken met de top 25% van dividendbetalers in de Australian markt ( 5.94% ).

Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn redelijke payout ratio ( 54.9% ) worden de dividendbetalingen van VLS gedekt door de winst.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Met zijn redelijk lage cash payout ratio ( 48.5% ) worden de dividendbetalingen van VLS goed gedekt door de kasstromen.

Vita Life Sciences Dividend

Dividend criteriumcontroles 4/6

Belangrijke informatie

Recente dividendupdates

Upcoming dividend of AU$0.06 per share

Upcoming dividend of AU$0.03 per share at 3.7% yield

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Upcoming dividend of AU$0.033 per share at 3.9% yield

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

Recent updates

Non-Executive Chairman recently sold AU$654k worth of stock

New minor risk - Insider selling

MD & Director recently sold AU$1.9m worth of stock

Upcoming dividend of AU$0.06 per share

Vita Life Sciences Limited, Annual General Meeting, May 15, 2024

Final dividend increased to AU$0.06

Full year 2023 earnings released: EPS: AU$0.17 (vs AU$0.13 in FY 2022)

Less than half of directors are independent

Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share at 3.7% yield

Less than half of directors are independent

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

Upcoming dividend of AU$0.033 per share at 3.9% yield

No independent directors

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

No independent directors

No independent directors

No independent directors

No independent directors

Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022

No independent directors

Less than half of directors are independent

Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

First half 2022 earnings released: EPS: AU$0.069 (vs AU$0.07 in 1H 2021)

Less than half of directors are independent

Less than half of directors are independent

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2021, Payable on April 7, 2022

Less than half of directors are independent

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Upcoming dividend of AU$0.028 per share

First half 2021 earnings released: EPS AU$0.07 (vs AU$0.058 in 1H 2020)

Less than half of directors are independent

Less than half of directors are independent

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2021

Upcoming Dividend of AU$0.015 Per Share

Earnings released

Stabiliteit en groei van betalingen

Dividendrendement versus markt

Winstuitkering aan aandeelhouders

Contante uitbetaling aan aandeelhouders

Ontdek bedrijven met een sterk dividend